Pfizer Inc (PFE)

$27.22 +0.03 (0.11%)
Market Cap 154.15B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.46
Forward PE 9.17
Profit Margin 12.42%
Debt to Equity Ratio 0.75
Volume 21,779,291
Avg Vol 42,001,801
Day's Range N/A - N/A
Shares Out 5.69B
Stochastic %K 25%
Beta 0.43
Analysts Sell
Price Target $29.05

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Tiger65
Tiger65 Apr. 16 at 8:41 PM
$PFE that’s a good question. It definitely closed green on Friday after the last ER. I understand the actual slightly bearish sentiment due to the selloff that was caused by profittaking in my opinion. The stock has clearly lost shortterm momentum. Uptrend is still intact thoug. The one good thing about the company is that it is definitely not a one-trick pony. I’m inclined to believe that the management has invested that massive cash from Covid drugs wisely somehow and it will pay off in the future. But who can tell the future.
0 · Reply
doubleuptwice
doubleuptwice Apr. 16 at 8:20 PM
$PFE when was the last time this ran on a Friday?
1 · Reply
Tiger65
Tiger65 Apr. 16 at 7:48 PM
$PFE The stock just got a longterm recommendation from Schwab analysts due to the recent selloff. It looks cheap again, and they think it will continue to climb on the longer term. https://www.youtube.com/watch?v=ebS2-bBmoyI We might be headed into a surprise move in a week when we get a forcast for the ER and R&D. It will be interesting to hear about Metsera drugs stage development. The drugs seem to be longer lasting then it’s competitors.
0 · Reply
zerodayrounder
zerodayrounder Apr. 16 at 7:48 PM
is there a big battle brewing between $PFE IV drug emblaveo and $GSK oral tebipenem at ESCMID? wonder how $SPRO situated in between here?
0 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 16 at 7:39 PM
$PFE holy pinned
1 · Reply
_Meyers2times
_Meyers2times Apr. 16 at 7:23 PM
$SOPA $FSLY $PFE mind
0 · Reply
Typecheck
Typecheck Apr. 16 at 6:45 PM
$PFE volume dried up. What is happening?
1 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 16 at 5:43 PM
$PFE red lol
0 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 16 at 5:35 PM
$PFE basically flat for 2 months now
1 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Apr. 16 at 5:13 PM
$PFE - In a very parallel world, we're pulling an Intel
1 · Reply
Latest News on PFE
The Big 3: PFE, V, SYF

Apr 16, 2026, 1:01 PM EDT - 3 hours ago

The Big 3: PFE, V, SYF

SYF V

Big Pharma Is Turning to China for the Newest Drug Ideas

Apr 10, 2026, 11:00 PM EDT - 5 days ago

Big Pharma Is Turning to China for the Newest Drug Ideas

Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

Apr 9, 2026, 10:00 AM EDT - 7 days ago

Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

Why Is Pfizer Stock Dropping Tuesday?

Apr 7, 2026, 1:54 PM EDT - 9 days ago

Why Is Pfizer Stock Dropping Tuesday?

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

Apr 2, 2026, 11:14 AM EDT - 14 days ago

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

NVO LLY

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

Apr 1, 2026, 11:39 AM EDT - 15 days ago

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

BNTX

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

Apr 1, 2026, 10:13 AM EDT - 15 days ago

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

Mar 30, 2026, 10:44 AM EDT - 17 days ago

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

GSK LLY NVO PPH

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

Mar 24, 2026, 10:00 AM EDT - 23 days ago

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

Mar 23, 2026, 12:46 PM EDT - 24 days ago

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

VALN

Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive

Mar 23, 2026, 10:35 AM EDT - 24 days ago

Valneva-Pfizer Lyme Shot Stumbles Yet Keeps Regulatory Path Alive

VALN

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Mar 23, 2026, 9:36 AM EDT - 24 days ago

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

VALN

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Mar 23, 2026, 7:07 AM EDT - 24 days ago

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

VALN

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

Mar 23, 2026, 7:02 AM EDT - 24 days ago

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

VALN

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

Mar 23, 2026, 6:47 AM EDT - 24 days ago

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

VALN

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

Mar 23, 2026, 6:45 AM EDT - 24 days ago

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

VALN

5 ‘Healthy' Dividends Paying Up To 14.1%

Mar 22, 2026, 9:45 AM EDT - 25 days ago

5 ‘Healthy' Dividends Paying Up To 14.1%

ARE BME DOC HQH

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

Mar 20, 2026, 4:30 PM EDT - 27 days ago

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

Mar 19, 2026, 6:45 AM EDT - 4 weeks ago

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

TrumpRx lists many medicines at prices higher than paid in UK

Mar 18, 2026, 2:23 PM EDT - 4 weeks ago

TrumpRx lists many medicines at prices higher than paid in UK

ABBV AMGN AZN BMY GILD GSK JNJ

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Mar 17, 2026, 7:49 AM EDT - 4 weeks ago

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Mar 17, 2026, 6:45 AM EDT - 4 weeks ago

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Mar 9, 2026, 7:27 AM EDT - 5 weeks ago

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

Mar 9, 2026, 6:45 AM EDT - 5 weeks ago

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

China approves Pfizer GLP-1 drug for weight management

Mar 6, 2026, 12:40 AM EST - 5 weeks ago

China approves Pfizer GLP-1 drug for weight management

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

Mar 5, 2026, 4:48 PM EST - 5 weeks ago

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

Mar 4, 2026, 8:55 AM EST - 6 weeks ago

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

SMWB

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

Mar 3, 2026, 8:10 AM EST - 6 weeks ago

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields

PRGO XRAY

Pfizer CEO flags issues with FDA's vaccine leadership

Mar 2, 2026, 11:14 AM EST - 6 weeks ago

Pfizer CEO flags issues with FDA's vaccine leadership

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

Feb 27, 2026, 10:00 AM EST - 6 weeks ago

PADCEV™ + Keytruda® Cuts Risk of Recurrence or Death by Nearly 50% in Cisplatin-Eligible Muscle-Invasive Bladder Cancer

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Feb 24, 2026, 2:29 PM EST - 7 weeks ago

U.S. FDA Grants Full Approval to Pfizer's BRAFTOVI Combination Regimen in First-Line Metastatic Colorectal Cancer

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Feb 24, 2026, 7:45 AM EST - 7 weeks ago

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Pfizer in diabetes drug deal with Sciwind Biosciences

Feb 23, 2026, 10:26 PM EST - 7 weeks ago

Pfizer in diabetes drug deal with Sciwind Biosciences

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

Feb 23, 2026, 3:15 PM EST - 7 weeks ago

US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the cost

MRK MRNA

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Feb 23, 2026, 10:00 AM EST - 7 weeks ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Is There 25% Downside For Pfizer Stock?

Feb 18, 2026, 12:00 PM EST - 2 months ago

Is There 25% Downside For Pfizer Stock?

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Feb 17, 2026, 6:45 AM EST - 2 months ago

Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

Prices, pipelines and patent cliffs: Inside pharma's big reset

Feb 13, 2026, 6:13 AM EST - 2 months ago

Prices, pipelines and patent cliffs: Inside pharma's big reset

AMGN LLY NVO

These 32 favorite stocks signal the bull market is running on fumes

Feb 12, 2026, 8:05 AM EST - 2 months ago

These 32 favorite stocks signal the bull market is running on fumes

AAPL ABT ADBE AMGN AVGO BAC BK

Is Pfizer Stock Now A Value Trap?

Feb 11, 2026, 8:56 AM EST - 2 months ago

Is Pfizer Stock Now A Value Trap?

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Feb 10, 2026, 3:20 PM EST - 2 months ago

Pfizer to collect $29 million from SEC case against Steven A. Cohen hedge fund

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

Feb 6, 2026, 2:55 PM EST - 2 months ago

Healthy Returns: Pfizer execs chart out obesity strategy after encouraging drug data

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Feb 6, 2026, 6:45 AM EST - 2 months ago

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Feb 5, 2026, 7:09 PM EST - 2 months ago

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

Feb 3, 2026, 1:27 PM EST - 2 months ago

Obesity stocks slump on Novo's underwhelming 2026 sales forecast

ALT AMGN GPCR LLY NVO VKTX

Silver Surges Over 15%; Pfizer Earnings Top Views

Feb 3, 2026, 12:00 PM EST - 2 months ago

Silver Surges Over 15%; Pfizer Earnings Top Views

Pfizer, Merck report Q4 results: Citi's Geoff Meacham on key takeaways

Feb 3, 2026, 11:17 AM EST - 2 months ago

Pfizer, Merck report Q4 results: Citi's Geoff Meacham on key takeaways

MRK

Pfizer beats quarterly estimates despite Covid product decline - reaffirms modest outlook

Feb 3, 2026, 10:15 AM EST - 2 months ago

Pfizer beats quarterly estimates despite Covid product decline - reaffirms modest outlook

Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

Feb 3, 2026, 8:50 AM EST - 2 months ago

Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops

Pfizer maps post-Covid reset with obesity trials and deep cost cuts

Feb 3, 2026, 8:17 AM EST - 2 months ago

Pfizer maps post-Covid reset with obesity trials and deep cost cuts

Tiger65
Tiger65 Apr. 16 at 8:41 PM
$PFE that’s a good question. It definitely closed green on Friday after the last ER. I understand the actual slightly bearish sentiment due to the selloff that was caused by profittaking in my opinion. The stock has clearly lost shortterm momentum. Uptrend is still intact thoug. The one good thing about the company is that it is definitely not a one-trick pony. I’m inclined to believe that the management has invested that massive cash from Covid drugs wisely somehow and it will pay off in the future. But who can tell the future.
0 · Reply
doubleuptwice
doubleuptwice Apr. 16 at 8:20 PM
$PFE when was the last time this ran on a Friday?
1 · Reply
Tiger65
Tiger65 Apr. 16 at 7:48 PM
$PFE The stock just got a longterm recommendation from Schwab analysts due to the recent selloff. It looks cheap again, and they think it will continue to climb on the longer term. https://www.youtube.com/watch?v=ebS2-bBmoyI We might be headed into a surprise move in a week when we get a forcast for the ER and R&D. It will be interesting to hear about Metsera drugs stage development. The drugs seem to be longer lasting then it’s competitors.
0 · Reply
zerodayrounder
zerodayrounder Apr. 16 at 7:48 PM
is there a big battle brewing between $PFE IV drug emblaveo and $GSK oral tebipenem at ESCMID? wonder how $SPRO situated in between here?
0 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 16 at 7:39 PM
$PFE holy pinned
1 · Reply
_Meyers2times
_Meyers2times Apr. 16 at 7:23 PM
$SOPA $FSLY $PFE mind
0 · Reply
Typecheck
Typecheck Apr. 16 at 6:45 PM
$PFE volume dried up. What is happening?
1 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 16 at 5:43 PM
$PFE red lol
0 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 16 at 5:35 PM
$PFE basically flat for 2 months now
1 · Reply
PFElinepfrenzy1990
PFElinepfrenzy1990 Apr. 16 at 5:13 PM
$PFE - In a very parallel world, we're pulling an Intel
1 · Reply
Abouelyazeed
Abouelyazeed Apr. 16 at 4:58 PM
$BFRG Trump signals U.S. support for psychedelic PTSD treatments—igniting a new wave of biotech and AI-driven drug discovery plays like BFRG. $LLY $PFE $JNJ $NVS
0 · Reply
IndyOne
IndyOne Apr. 16 at 4:45 PM
$MRNA Moderna is an absolute work horse. V940 clinical results for Melanoma and NSCLC (Non-Small Cell Lung Cancer). V940 platform expansion includes renal cell carcinoma and bladder cancer. CEO committed to 10%+ revenue growth 2026. TELLS: October 2025: "Deal of significant scope" in discussion, buyout or massive partnership. December 2025: Stéphane Bancel, Moderna CEO, sold his six-level home in Boston where he had lived for +12 years. January 2026: Moderna and Merck announced V940 results showed a 49% reduction in the risk of recurrence or death. Keytruda goes off patent soon, Merck can use Moderna's mRNA-4157 (also known as intismeran autogene) a first-of-its-kind, personalized mRNA cancer vaccine to extend Keytruda protection. February 2026: Patent litigation resolved. NO ROYALTIES! HUGE WIN. Moderna wanted the decks clear, they could have fought this longer like Pfizer & BioNtech. Partnership or buyout coming from $MRK $PFE $RHHBY or $GSK .
0 · Reply
RichMitch
RichMitch Apr. 16 at 4:42 PM
$VVOS $LLY $BMY $PFE $REPL
0 · Reply
stockanalysis_
stockanalysis_ Apr. 16 at 4:38 PM
Here's How To Use StockAnalysis.com As a Full-Time Dividend Investor! $PFE $PEP $MO $VZ $KO https://www.youtube.com/watch?v=zY6rAhu_wng
0 · Reply
RichMitch
RichMitch Apr. 16 at 4:33 PM
$VVOS 👀 Hmmm 🤔 $LLY $BMY $PFE $SPY
0 · Reply
BioRich
BioRich Apr. 16 at 4:32 PM
$CMND the next runner? Recently hit Alcohol Use Disorder (AUD) trial Primary Endpoint. Did a raise, so that's behind us, and I believe federal regulations are around the corner supporting this type of treatment. Cheap so worth the risk IMHO. Follow/Subscribe for more suggestions and perspective. Would love to hear yours. that's how we find these gems and learn. Let's make some (more) money. Cheers! $XBI $ALT $LLY $PFE
0 · Reply
doubleuptwice
doubleuptwice Apr. 16 at 4:27 PM
$PFE just did my Malay load it’s at a 🔑 level. Will sell my whole position at $27 breakdown
0 · Reply
SparkyReturns
SparkyReturns Apr. 16 at 4:25 PM
$ICU Just in case there's anyone unfamiliar with ICU, Welcome to the Greatest Show on Earth! Buckle up. Up 6% but just getting started. 15M market cap currently.... yeah sure. TAM in the tens of Billions. $MRNA $LLY $PFE $AMGN
0 · Reply
ajbski
ajbski Apr. 16 at 3:53 PM
$NVAX 🔥🔥🔥New COVID-19 Vaccine published study in Health Care Workers and 1st Responders: Matrix-M adjuvanted protein-based NVX (Nuvaxovid: Novavax) COVID-19 vaccine has a significantly lower impact on daily life vs. mRNA-based (Comirnaty: Pfizer) COVID-19 vaccine. $PFE #Biotech http://academic.oup.com/ofid/article/1…
0 · Reply
rolandzaner
rolandzaner Apr. 16 at 3:44 PM
$PFE dissapointed
0 · Reply
Bleu_
Bleu_ Apr. 16 at 2:47 PM
$PFE I will buy!
0 · Reply
Micheal_Pothead
Micheal_Pothead Apr. 16 at 2:32 PM
$PFE a morning pop and a walk down?
0 · Reply